TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16537378

Group type: EXPERIMENTAL
Intervention: High-dose oral N-acetylcysteine (0.6 to 1.0 g three times daily, for 4 weeks)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High-dose oral N-acetylcysteine
Number of subjects: 18
Study: 12773587

Group type: EXPERIMENTAL
Intervention: Pallidotomy surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (age-matched subjects)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients with Parkinson's disease (before surgery)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients with Parkinson's disease (after surgery)
Number of subjects: 0
Study: 11130773

Group type: EXPERIMENTAL
Intervention: Losartan (100 mg/day for 8 days)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 9058689

Group type: EXPERIMENTAL
Intervention: Inhaled heparin (15,000 units USP/ml, 4 ml)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 8104097

Group type: EXPERIMENTAL
Intervention: Intravenous benztropine (2 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Propranolol (1 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 6
Study: 3732769

Group type: EXPERIMENTAL
Intervention: Chenodiol (chenodeoxycholate), 750 mg/day
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Chenodiol (chenodeoxycholate), 375 mg/day
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Chenodiol (chenodeoxycholate)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 31876024

Group type: EXPERIMENTAL
Intervention: Mindfulness practice
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 47
Study: 29779170

Group type: EXPERIMENTAL
Intervention: Oligofructose (8 g/day for 12 weeks followed by 16 g/day for 24 weeks)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Isocaloric placebo
Number of subjects: 14
Study: 28556188

Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 13

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 13
Study: 25805405

Group type: EXPERIMENTAL
Intervention: Positive imagery cognitive bias modification (CBM)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Both groups (CBM and control)
Number of subjects: 75
Study: 23258641

Group type: EXPERIMENTAL
Intervention: Transdermal electromotive administration of verapamil (10 mg) and dexamethasone (4 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intra-lesional injection of verapamil (10 mg) and dexamethasone (4 mg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Transdermal electromotive administration of verapamil and dexamethasone
Number of subjects: 60
Study: 21291509

Group type: EXPERIMENTAL
Intervention: Teams that exhibited stated recognition of the emergency (eclampsia) earlier.
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Teams that managed the critical task using closed‐loop communication.
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Teams that administered magnesium sulfate within the allocated time (10 minutes).
Number of subjects: 114
Study: 20081574

Group type: EXPERIMENTAL
Intervention: 12-week progressive resistance exercise programme using heel raises in addition to compression
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care in addition to compression
Number of subjects: 40
Study: 16622171

Group type: EXPERIMENTAL
Intervention: Computerized clinical decision support system (CDSS) added to computerized physician order entry (CPOE) system
Number of subjects: 445

Group type: COMPARATOR
Intervention: Control units without alerts
Number of subjects: 445
Study: 15050862

Group type: EXPERIMENTAL
Intervention: Dexamethasone (1 mg and 2 mg on 2 successive days)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 11777667

Group type: EXPERIMENTAL
Intervention: Aftercare program (n = 62)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Control group (n = 51)
Number of subjects: 145
Study: 9489052

Group type: EXPERIMENTAL
Intervention: Methadone maintenance treatment
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Methadone doses
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Year of enrollment
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Stable income
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: History of opioid use
Number of subjects: 111
Study: 7957160

Group type: EXPERIMENTAL
Intervention: Controlled diet
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Regular physical training
Number of subjects: 90

Group type: COMPARATOR
Intervention: Unlimited exercise
Number of subjects: 90

Group type: COMPARATOR
Intervention: Ad libitum diet
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Anxiety levels
Number of subjects: 90
Study: 3612036

Group type: EXPERIMENTAL
Intervention: Predictive instrument for acute ischemic heart disease
Number of subjects: 0
Study: 29493105

Group type: EXPERIMENTAL
Intervention: VSL#3®
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 27071477

Group type: EXPERIMENTAL
Intervention: Experimental Group (EG) - Four weeks of APA-focused training involving catching a medicine ball while standing
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control Group (CG) - No training
Number of subjects: 6
Study: 24694794

Group type: EXPERIMENTAL
Intervention: AST-120 (2 g 3 times daily for 8 weeks)
Number of subjects: 249

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: AST-120
Number of subjects: 249

Group type: COMPARATOR
Intervention: AST-120 and Placebo
Number of subjects: 249
Study: 22348845

Group type: EXPERIMENTAL
Intervention: 1.5 ml 0.75% ropivacaine to the tonsil lodge
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 1 mg/kg i.v. tramadol
Number of subjects: 90

Group type: COMPARATOR
Intervention: i.v. saline (placebo group)
Number of subjects: 90
Study: 21054850

Group type: EXPERIMENTAL
Intervention: Selective V(2)R-antagonist (1 μg/kg per hour)
Number of subjects: 21

Group type: COMPARATOR
Intervention: AVP (0.05 μg/kg per hour)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 21
Study: 18320520

Group type: EXPERIMENTAL
Intervention: 1.25 mg intravitreal bevacizumab
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Avastin-treated eyes
Number of subjects: 40
Study: 15947724

Group type: EXPERIMENTAL
Intervention: Closed-ended STAR questionnaire
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Open-ended STAR questionnaire
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Self-report instruments
Number of subjects: 104
Study: 12356631

Group type: EXPERIMENTAL
Intervention: 7-hexanoyltaxol-eluting stents (qDES)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Bare metal stents (BMS)
Number of subjects: 122
Study: 10686834

Group type: EXPERIMENTAL
Intervention: Rigid fixation
Number of subjects: 117

Group type: COMPARATOR
Intervention: Wire fixation
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Presurgical oral health (OHSQ)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Global Severity Index (GSI) score from SCL-90-R
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Psychosocial scale score from SIP
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: GSI, SIP, and OHSQ
Number of subjects: 117
Study: 8850174

Group type: EXPERIMENTAL
Intervention: Increased serum cTnT
Number of subjects: 79

Group type: COMPARATOR
Intervention: Increased serum CK‐MB
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Negative serum cTnT
Number of subjects: 79

Group type: COMPARATOR
Intervention: Negative serum CK‐MB
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Unexplained cTnT elevations
Number of subjects: 79
Study: 1928808

Group type: EXPERIMENTAL
Intervention: Nifedipine GITS
Number of subjects: 49

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 49
Study: 6285280

Group type: EXPERIMENTAL
Intervention: Isaxonine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 31191268

Group type: EXPERIMENTAL
Intervention: Multivitamin/mineral supplement
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Vitamin D supplement
Number of subjects: 60

Group type: COMPARATOR
Intervention: Vitamin C (control)
Number of subjects: 60
Study: 29063307

Group type: EXPERIMENTAL
Intervention: P4HB mesh
Number of subjects: 121
Study: 29786356

Group type: EXPERIMENTAL
Intervention: ACNB+COX‐2 (group A)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: COX‐2 (group B)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 90
Study: 25091284

Group type: EXPERIMENTAL
Intervention: Low-GR liquid meal replacement (Glucerna SR)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Free-choice breakfast
Number of subjects: 20

Group type: COMPARATOR
Intervention: Isoenergetic control breakfast
Number of subjects: 20
Study: 21992533

Group type: EXPERIMENTAL
Intervention: More Intensive (MI) regimen of belatacept
Number of subjects: 666

Group type: EXPERIMENTAL
Intervention: Less Intensive (LI) regimen of belatacept
Number of subjects: 666

Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 666
Study: 21265120

Group type: EXPERIMENTAL
Intervention: Vasonat
Number of subjects: 0
Study: 17671059

Group type: EXPERIMENTAL
Intervention: Computer kiosk intervention (Safety in Seconds program)
Number of subjects: 759

Group type: COMPARATOR
Intervention: Control group (report on other child health topics)
Number of subjects: 759
Study: 15691303

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg twice daily
Number of subjects: 200

Group type: COMPARATOR
Intervention: Omeprazole 20 mg twice daily
Number of subjects: 200
Study: 12609711

Group type: EXPERIMENTAL
Intervention: Pro12Ala polymorphism in PPAR-gamma gene
Number of subjects: 381
Study: 10709535

Group type: EXPERIMENTAL
Intervention: Active distraction technique (repeated deep breathing and blowing out air)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (injection given in a slow manner without the distraction technique)
Number of subjects: 50
Study: 7778005

Group type: EXPERIMENTAL
Intervention: Lumbar body support (LBS)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Flat conventional mattress
Number of subjects: 10
Study: 1683217

Group type: EXPERIMENTAL
Intervention: 400 mg/day oral celiprolol
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 120 mg/day oral nicardipine
Number of subjects: 17
Study: 7299629

Group type: EXPERIMENTAL
Intervention: Engagement in 12 pleasurable activities
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Engagement in 2 pleasurable activities
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no activities, retesting after 1 month)
Number of subjects: 0
Study: 31198048

Group type: EXPERIMENTAL
Intervention: Physical activity coaching program (18 months, monthly follow-up by physiotherapist)
Number of subjects: 380

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Physical activity coaching program
Number of subjects: 380
Study: 28445476

Group type: EXPERIMENTAL
Intervention: Online get-out-the-vote message
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Close friends of those who received the message
Number of subjects: 0
Study: 25577201

Group type: EXPERIMENTAL
Intervention: GflaxLC (32% of carbohydrate and 60g of flaxseed powder per day)
Number of subjects: 27

Group type: COMPARATOR
Intervention: GriceLC (35% of carbohydrate and 60g of raw rice powder per day)
Number of subjects: 27
Study: 23720981

Group type: EXPERIMENTAL
Intervention: Zinc sulfate supplementation (50 mg per meal, three times a day)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo (identically appearing)
Number of subjects: 144
Study: 21083540

Group type: EXPERIMENTAL
Intervention: Ketorolac (0.5 mg/kg bolus, 83.3 microg/kg/h infusion for 48 h)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Fentanyl (1 microg/kg bolus, 0.17 microg/kg/h infusion for 48 h)
Number of subjects: 52
Study: 19407226

Group type: EXPERIMENTAL
Intervention: tPA
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 17538877

Group type: EXPERIMENTAL
Intervention: Antiretroviral prophylaxis
Number of subjects: 1256

Group type: EXPERIMENTAL
Intervention: Weaning at 6 months
Number of subjects: 1256
Study: 15534261

Group type: EXPERIMENTAL
Intervention: Antioxidants (vitamin C, 500 mg; vitamin E, 400 IU; beta carotene, 15 mg)
Number of subjects: 2166

Group type: EXPERIMENTAL
Intervention: Zinc and copper (zinc, 80 mg; cupric oxide, 2 mg)
Number of subjects: 2166

Group type: EXPERIMENTAL
Intervention: Antioxidants plus zinc and copper
Number of subjects: 2166

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2166
Study: 16313112

Group type: EXPERIMENTAL
Intervention: Feiyangqin Rectum Condensed Liquid (FRCL)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Western medicine (control)
Number of subjects: 72
Study: 10588093

Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil
Number of subjects: 217

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 217
Study: 8905537

Group type: EXPERIMENTAL
Intervention: Initial Error group (n = 11)
Number of subjects: 23

Group type: COMPARATOR
Intervention: No Initial Error group (n = 12)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Training on the WCST for all subjects
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Previous error history
Number of subjects: 23
Study: 1671326

Group type: EXPERIMENTAL
Intervention: Fenoterol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Metaproterenol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Isoproterenol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Epinephrine
Number of subjects: 12
Study: 6295339

Group type: EXPERIMENTAL
Intervention: Third-generation cephalosporins (moxalactam disodium, cefotaxime sodium, cefoperazone sodium)
Number of subjects: 808

Group type: COMPARATOR
Intervention: Gentamicin sulfate plus clindamycin
Number of subjects: 808
Study: 31606455

Group type: EXPERIMENTAL
Intervention: Obeticholic acid (OCA) 5 to 10 mg daily
Number of subjects: 17
Study: 30367320

Group type: EXPERIMENTAL
Intervention: Family planning support
Number of subjects: 320

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 320
Study: 28854396

Group type: EXPERIMENTAL
Intervention: 3 × 20 min a week of minimally supervised (3MS)
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: 1 × 60 min a week of supervised high-intensity strength training (1WS)
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: 3 × 20 min a week of supervised high-intensity strength training (3WS)
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: 9 × 7 min a week of supervised high-intensity strength training (9WS)
Number of subjects: 573

Group type: COMPARATOR
Intervention: Reference group without training (REF)
Number of subjects: 573
Study: 26561301

Group type: EXPERIMENTAL
Intervention: MCT/LCT
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: OO
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: MCT/LCT and SO
Number of subjects: 156

Group type: COMPARATOR
Intervention: SOD, MDA, GSH‐Px, and T‐AOC
Number of subjects: 156
Study: 25001959

Group type: EXPERIMENTAL
Intervention: Weight loss intervention (‐30% energy)
Number of subjects: 0
Study: 21735193

Group type: EXPERIMENTAL
Intervention: Acetic acid-moistened misoprostol tablets
Number of subjects: 322

Group type: COMPARATOR
Intervention: Dry misoprostol tablets
Number of subjects: 322
Study: 19054024

Group type: EXPERIMENTAL
Intervention: PTCA (Percutaneous Transluminal Coronary Angioplasty)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 280
Study: 18086984

Group type: EXPERIMENTAL
Intervention: Robotic telerounds
Number of subjects: 270

Group type: COMPARATOR
Intervention: Standard bedside rounds
Number of subjects: 270
Study: 15136504

Group type: EXPERIMENTAL
Intervention: Pravastatin treatment (MTP-493GG genotype)
Number of subjects: 1740

Group type: COMPARATOR
Intervention: MTP-493GT genotype
Number of subjects: 1740

Group type: COMPARATOR
Intervention: MTP-493TT genotype
Number of subjects: 1740

Group type: EXPERIMENTAL
Intervention: Pravastatin treatment
Number of subjects: 1740
Study: 12365880

Group type: EXPERIMENTAL
Intervention: Psychological intervention
Number of subjects: 220

Group type: COMPARATOR
Intervention: Nortriptyline
Number of subjects: 220

Group type: COMPARATOR
Intervention: Bupropion
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study: 9572789

Group type: EXPERIMENTAL
Intervention: Vibratory stimulation (100 Hz) during inspiration with inspiratory load
Number of subjects: 10
Study: 7924329

Group type: EXPERIMENTAL
Intervention: In situ corneal excision (IS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Whole globe enucleation (EN)
Number of subjects: 24
Study: 29570475

Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (high-dose corticosteroids)
Number of subjects: 0
Study: 27883227

Group type: EXPERIMENTAL
Intervention: Music their mothers listened to during pregnancy
Number of subjects: 42

Group type: COMPARATOR
Intervention: No music
Number of subjects: 42

Group type: COMPARATOR
Intervention: Recorded lullabies
Number of subjects: 42
Study: 26272328

Group type: EXPERIMENTAL
Intervention: Fast food consumption after high intensity interval exercise (HIIE)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fast food consumption after moderate intensity exercise (MIE)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fast food consumption after no exercise (NE)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fast food consumption in type 2 diabetes individuals
Number of subjects: 10

Group type: COMPARATOR
Intervention: Fast food consumption in controls
Number of subjects: 10
Study: 23299763

Group type: EXPERIMENTAL
Intervention: Acute oral antioxidant cocktail (AOC, vitamins C and E, and alpha‐lipoic acid)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Acute oral antioxidant cocktail (AOC, vitamins C and E, and alpha‐lipoic acid) in patients with high basal free radicals
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Acute oral antioxidant cocktail (AOC, vitamins C and E, and alpha‐lipoic acid) in patients with low basal free radicals
Number of subjects: 10
Study: 21943625

Group type: EXPERIMENTAL
Intervention: PNF stretching before eccentric exercise
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (no PNF stretching)
Number of subjects: 28
Study: 18241359

Group type: EXPERIMENTAL
Intervention: Olanzapine (n=19)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Unmedicated (n=19)
Number of subjects: 38
Study: 16856899

Group type: EXPERIMENTAL
Intervention: Full-mouth debridement with water
Number of subjects: 36

Group type: COMPARATOR
Intervention: Quadrant-wise debridement
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Full-mouth debridement with povidone iodine
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Full-mouth debridement (both types)
Number of subjects: 36
Study: 12639160

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba 120 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11043871

Group type: EXPERIMENTAL
Intervention: Additional-exercise treatment group (AT group)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Regular treatment group (RT group)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Both groups (AT and RT)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Nonsymptomatic patients
Number of subjects: 59
Study: 9124404

Group type: EXPERIMENTAL
Intervention: Insulin-like growth factor (IGF-I) 100 microg/kg subcutaneously every 12 h for 6 doses
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 9702254

Group type: EXPERIMENTAL
Intervention: Antiviral and immunostimulative treatment with Romanian specific products
Number of subjects: 16
Study: 3520161

Group type: EXPERIMENTAL
Intervention: Cold blood cardioplegia and warm blood cardioplegia (hot shot)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cold blood cardioplegia
Number of subjects: 20
Study: 29705482

Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation (PMR) for eight weeks
Number of subjects: 91

Group type: COMPARATOR
Intervention: Routine cares (Control)
Number of subjects: 91
Study: 27419471

Group type: EXPERIMENTAL
Intervention: fractional laser plus topical lidocaine cream (Group LaserAnes)
Number of subjects: 22

Group type: COMPARATOR
Intervention: sham irradiation plus topical anesthesia (Group Anes)
Number of subjects: 22

Group type: COMPARATOR
Intervention: sham irradiation plus sham anesthesia (Group Con)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Group LaserAnes
Number of subjects: 22

Group type: COMPARATOR
Intervention: Group Anes
Number of subjects: 22
Study: 23900888

Group type: EXPERIMENTAL
Intervention: Silk sericin-releasing wound dressing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bactigras®
Number of subjects: 0
Study: 22239857

Group type: EXPERIMENTAL
Intervention: Outdoor Adventure Group (OAG)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Other Psychosocial Recovery Group Program groups (Control)
Number of subjects: 33
Study: 19686437

Group type: EXPERIMENTAL
Intervention: HGM-3 index
Number of subjects: 195
Study: 18006189

Group type: EXPERIMENTAL
Intervention: Ondansetron (0.15 mg/kg orally dissolving tablet)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 106
Study: 16356219

Group type: EXPERIMENTAL
Intervention: Post-operative goal-directed therapy (GDT)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Conventional management (control)
Number of subjects: 122
Study: 12434938

Group type: EXPERIMENTAL
Intervention: Medical nutrition therapy (MNT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 90